Fabio A. Franke
Ijui, RS, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
From Diagnosis to Execution: A National Plan Proposal to Redesign Clinical Research in Brazil to Improve Cancer Care and Innovation Access.
Journal: JCO global oncology
Published: April 29, 2026
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer.
Journal: The New England journal of medicine
Published: June 02, 2025
Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis.
Journal: Nature cancer
Published: January 13, 2025
Androgen Receptor Pathway Inhibitor Therapy for Advanced Prostate Cancer: Secondary Analysis of a Randomized Clinical Trial.
Journal: JAMA network open
Published: January 13, 2025
TROPION-Lung07: Phase III study of Dato-DXd + pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer.
Journal: Future oncology (London, England)
Published: October 29, 2024
Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 22, 2024
Phase 1 Clinical Trials: Challenges and Opportunities in Latin America.
Journal: Journal of immunotherapy and precision oncology
Published: November 06, 2023
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 31, 2023
heredERA Breast Cancer: a phase III, randomized, open-label study evaluating the efficacy and safety of giredestrant plus the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with previously untreated HER2-positive, estrogen receptor-positive locally advanced or metastatic breast cancer.
Journal: BMC cancer
Published: August 04, 2023
Correlation between work productivity loss and EORTC QLQ-C30 and -BR23 domains from the MONALEESA-7 trial of premenopausal women with HR+/HER2- advanced breast cancer.
Journal: Therapeutic advances in medical oncology
Published: October 26, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 01, 2021
Last Updated: 09/26/2026